A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies

por Valton, Julien, Guyot, Valerie, Boldajipour, Bijan, Sommer, Cesar, Pertel, Thomas, Juillerat, Alexandre, Duclert, Aymeric, Sasu, Barbra Johnson, Duchateau, Philippe, Poirot, Laurent
Publicado 2018

Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models

por Lin, Regina J., Sutton, Janette, Bentley, Trevor, Vargas-Inchaustegui, Diego A., Nguyen, Duy, Cheng, Hsin-Yuan, Yoon, Hayung, Van Blarcom, Thomas J., Sasu, Barbra J., Panowski, Siler H., Sommer, Cesar
Publicado 2023

Direct control of CAR T cells through small molecule-regulated antibodies

por Park, Spencer, Pascua, Edward, Lindquist, Kevin C., Kimberlin, Christopher, Deng, Xiaodi, Mak, Yvonne S. L., Melton, Zea, Johnson, Theodore O., Lin, Regina, Boldajipour, Bijan, Abraham, Robert T., Pons, Jaume, Sasu, Barbra Johnson, Van Blarcom, Thomas J., Chaparro-Riggers, Javier
Publicado 2021

Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

por Metelo, Ana M., Jozwik, Agnieszka, Luong, Le Anh, Dominey-Foy, Delaney, Graham, Charlotte, Attwood, Charlotte, Inam, Shafqat, Dunlop, Alan, Sanchez, Katy, Cuthill, Kirsty, Rice, Carmel, Streetly, Matthew, Bentley, Trevor, Boldajipour, Bijan, Sommer, Cesar, Sasu, Barbra, Benjamin, Reuben
Publicado 2022